Viatris Inc
Customers
4
1 disclosed, 1 prime contractor
Suppliers
1
1 disclosed
Largest customer
11%
COR · FY to 2025-12-31
Named-customer revenue
$1.6B
1 customer · FY to 2025-12-31
Latest period
Dec 31, 2025
10-K filed 2026-03-23
Customers 3
Companies VTRS discloses as major customers, as a share of VTRS revenue. 1 active, 2 lapsed.
| Company | % of VTRS revenue | Est. revenue | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| COR Distributor Cencora, Inc. |
11% | $1.6B | FY 2025-12-31 | −1.0pp | Active | 10-K 2026-02-26 |
Cencora, Inc. 11 % 12 % 10 % Cencora, Inc. (formerly AmerisourceBergen Corporation) 12 % 10 % 10 % AmerisourceBergen Corporation 10 % 10 % 9 % AmerisourceBergen Corporation 10 % 9 % 10 % | ||||||
| MCK Distributor MCKESSON CORP |
10% | $1.5B | FY 2023-12-31 | −1.0pp | Lapsed Last seen 2023-12-31 |
10-K 2026-02-26 |
McKesson Corporation * * 10 % McKesson Corporation * 10 % 11 % McKesson Corporation 10 % 11 % 9 % McKesson Corporation 11 % 9 % 13 % | ||||||
| CAH Distributor CARDINAL HEALTH INC |
5% | $769.4M | FY 2023-12-31 | ±0.0pp | Lapsed Last seen 2023-12-31 |
10-K 2026-02-26 |
Cardinal Health, Inc. * * 5 % Cardinal Health, Inc. * 5 % 5 % Cardinal Health, Inc. 5 % 5 % 5 % Cardinal Health, Inc. 5 % 5 % 8 % | ||||||
Suppliers 1
Companies that disclose VTRS as a major customer, as a share of their own revenue. 1 active, 0 lapsed.
| Company | % of their revenue | Est. $ from VTRS | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| Theravance Biopharma, Inc. Theravance Biopharma, Inc. |
100% | $107.5M | FY 2025-12-31 | ±0.0pp | Active | 10-K 2026-03-23 |
YUPELRI net sales (100% recorded by Viatris) $ 266,600 $ 238,626 $ 27,974 12 % YUPELRI net sales (100% recorded by Viatris) $ 238,626 $ 220,962 $ 17,664 8 % Viatris 100 % 95 % Viatris 95 % 79 % 63 % Viatris 79 % 63 % 44 % | ||||||
Federal subcontracts received 1
Prime contractors that subcontracted federal work to this company. From USAspending.gov subaward reports; amounts are as reported by the prime contractor, latest report per subaward, $500K+ a year.
| Company | Subawards | Fiscal year | Count | Trend | Largest subaward |
|---|---|---|---|---|---|
| Chemonics International, INC. | $17.1M | FY 2025 | 1 | AIDOAATO1500007 | |
THE PURPOSE OF THIS SUBCONTRACT IS TO ENTER INTO AN IDIQ FOR THE SUPPLY OF ARVS MANUFACTURED BY MYLAN LABORATORIES LIMITED FOR USE IN MULTIPLE COUNTRIES SUPPORTED BY THE GHSC-PSM PROJECT. | |||||
Named as competitors
Companies this filer names as competitors.
Alerts are coming
Get an email when VTRS's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.